2006
DOI: 10.1248/bpb.29.634
|View full text |Cite
|
Sign up to set email alerts
|

Anti-inflammatory Effect of Pitavastatin on NF-.KAPPA.B Activated by TNF-.ALPHA. in Hepatocellular Carcinoma Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
31
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(31 citation statements)
references
References 37 publications
0
31
0
Order By: Relevance
“…activates apoptosis and autophagy resulting in synergistic cytotoxicity in melanoma cells ABEER AL-QATATI 1 and SAEB ALIWAINI On a molecular level, pitavastatin treatment has been demonstrated to upregulate the cell cycle regulator p21 and to inhibit nuclear factor-κB (NF-κB) in different tumour cells, which resulted in cell cycle arrest and apoptosis (13,14). Finally, in glioma cells, autophagic cell death was demonstrated to be a potential mechanism of pitavastatin-induced cytotoxicity by also resulting in the inhibition of NF-κB (15).…”
Section: Combined Pitavastatin and Dacarbazine Treatmentmentioning
confidence: 99%
“…activates apoptosis and autophagy resulting in synergistic cytotoxicity in melanoma cells ABEER AL-QATATI 1 and SAEB ALIWAINI On a molecular level, pitavastatin treatment has been demonstrated to upregulate the cell cycle regulator p21 and to inhibit nuclear factor-κB (NF-κB) in different tumour cells, which resulted in cell cycle arrest and apoptosis (13,14). Finally, in glioma cells, autophagic cell death was demonstrated to be a potential mechanism of pitavastatin-induced cytotoxicity by also resulting in the inhibition of NF-κB (15).…”
Section: Combined Pitavastatin and Dacarbazine Treatmentmentioning
confidence: 99%
“…Furthermore, in multiple myeloma, CAM-DR is accompanied by increased geranylgeranylation of RhoA and activation of Rho kinase, whereas inhibition of this pathway can overcome drug resistance [155]. Geranylgeranylation is HMG-CoA-reductasedependent, and inhibition of HMG-CoA reductase suppresses the transcriptional activity of the NFkB promoter in hepatocellular carcinoma [188]. Similarly, in gastric cancer function neutralizing antibodies to v 3 inhibit cysteine-rich-61-mediated NFkB activation and thus cell invasiveness [189].…”
Section: Adhesion Associated Pathwaysmentioning
confidence: 99%
“…The nuclear fraction was prepared essentially as described by Wang et al [14]. The protein concentration was determined using the Bio-Rad protein assay reagent according to the manufacturer's instruction.…”
Section: Western Blot Analysis For Nf-kb Activation In Ammentioning
confidence: 99%